US Stock Market Closed

Dashboard

Rockwell Medical, Inc. (RMTI)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

H

Management & Equity

S

Analyst Opinion

S

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

About

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Hackensack, NJ.

CEO

Russell H. Ellison

Employees

299

Industry

-

Sector

-

Headquarters

Hackensack

Exchange

NASDAQ

Summary Stats

Market Cap

11.9M

Revenue

66.1M

Net Income

-28.7M

EPS

-$0.94

Price-to-Earnings

-1.36

Price-to-Book

0.59

Debt-to-Equity

1.94

News

Analyst Ratings

Price targets projected by 2 analysts

High

$9.00

Average

$7.00

Low

$5.00

Ratings calculated by 2 analysts

Buy

2

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q2 2022

Last Earnings

Above by $0.33

Actual

-$0.56 +37.1%

Consensus

-0.89

Report Date

Year Ago

-0.09

Year Ago Change %

Down 522%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites